Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen Price : 218.11 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 217.76 | 219.12 | 215.00 | 216.78 | 722348.0 |
| Aug 20, 2026 | 217.98 | 221.29 | 214.16 | 214.35 | 808625.0 |
| Aug 19, 2026 | 215.33 | 222.15 | 215.08 | 221.56 | 886914.0 |
| Aug 18, 2026 | 211.00 | 214.06 | 210.01 | 212.55 | 694009.0 |
| Aug 17, 2026 | 208.36 | 210.49 | 207.62 | 209.15 | 617238.0 |
| Aug 14, 2026 | 210.01 | 210.79 | 208.22 | 209.83 | 554816.0 |
| Aug 13, 2026 | 212.98 | 215.60 | 208.79 | 210.65 | 860095.0 |
| Aug 12, 2026 | 203.52 | 209.22 | 201.00 | 208.87 | 789441.0 |
| Aug 11, 2026 | 206.63 | 207.57 | 203.53 | 203.89 | 936835.0 |
| Aug 10, 2026 | 206.70 | 210.02 | 206.29 | 207.13 | 706425.0 |
| Aug 07, 2026 | 207.38 | 208.31 | 204.16 | 207.94 | 840566.0 |
| Aug 06, 2026 | 208.75 | 209.03 | 202.03 | 206.28 | 892772.0 |
| Aug 05, 2026 | 210.60 | 212.18 | 205.80 | 206.63 | 873781.0 |
| Aug 04, 2026 | 200.96 | 209.74 | 199.93 | 208.45 | 1.206M |
| Aug 03, 2026 | 203.34 | 203.85 | 199.58 | 201.82 | 940993.0 |
| Jul 31, 2026 | 207.51 | 208.05 | 202.57 | 202.95 | 1.062M |
| Jul 30, 2026 | 204.38 | 210.18 | 203.09 | 207.93 | 892938.0 |
| Jul 29, 2026 | 210.50 | 218.59 | 206.26 | 209.23 | 2.400M |
| Jul 28, 2026 | 201.01 | 207.72 | 199.40 | 205.61 | 1.832M |
| Jul 27, 2026 | 202.75 | 204.47 | 199.83 | 200.14 | 762581.0 |
| Jul 24, 2026 | 202.24 | 203.30 | 200.04 | 202.19 | 596372.0 |
| Jul 23, 2026 | 197.04 | 203.60 | 196.92 | 200.62 | 1.032M |
| Jul 22, 2026 | 203.70 | 204.30 | 197.40 | 197.74 | 841350.0 |
| Jul 21, 2026 | 199.47 | 203.70 | 198.59 | 203.16 | 652841.0 |
| Jul 20, 2026 | 204.08 | 205.65 | 199.62 | 199.95 | 963088.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 62.03 |
| AbbVie, Inc. | 264.49 |
| Gilead Sciences, Inc. | 146.76 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
| Amgen, Inc. | 443.84 |
Price Related Metrics
| PE Ratio | 38.63 |
| PS Ratio | 3.335 |
| Price to Book Value | 1.709 |
| Price to Free Cash Flow | 12.94 |
| Earnings Yield | 2.59% |
| Market Cap | 32.21B |
| Operating PE Ratio | 17.11 |
| Normalized PE Ratio | 23.87 |